领航医药生物科技(00399.HK)拟折让约9.78%配售最多1.45亿股 净筹5882.5万港元

Core Viewpoint - The company, Vanguard Pharmaceuticals (00399.HK), has entered into a placement agreement to issue up to 145 million shares at a price of HKD 0.415 per share, which represents a discount of approximately 9.78% from the closing price of HKD 0.460 on the date of the agreement [1] Group 1 - The placement is expected to involve at least six independent third-party subscribers [1] - The estimated net proceeds from the placement, after deducting related expenses of approximately HKD 1.35 million, are expected to be around HKD 58.825 million [1] - The company intends to use the net proceeds entirely for funding the development of its blockchain technology business [1]